Qiagen ( (QGEN) ) has provided an announcement.
Qiagen N.V. announced a managerial transaction involving Metin Colpan, a member of the administrative or supervisory body, which included the release of restricted stock units and the grant of new ones. This transaction reflects the company’s ongoing commitment to aligning managerial incentives with shareholder interests, potentially impacting its financial structuring and stakeholder relations.
More about Qiagen
Qiagen N.V. is a prominent player in the biotechnology industry, specializing in providing sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. The company is listed on various stock exchanges, including the Frankfurt Stock Exchange and NYSE, and operates globally with a focus on enhancing the health and safety of people worldwide.
YTD Price Performance: -13.75%
Average Trading Volume: 1,094,687
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $8.36B
For an in-depth examination of QGEN stock, go to TipRanks’ Stock Analysis page.